Eurofins Scientific Acquires 70,000 of Its Own Shares for 4.7 Million Euros
Eurofins Scientific purchased 70,000 of its own shares between January 5 and January 9, 2026, for a total amount of 4.7 million euros, according to the company's statement. The weighted average price was 67.5971 euros per share.
Details of the Transaction
The transaction took place over five consecutive trading days, the company reports. On January 5, Eurofins acquired 29,926 shares at an average price of 65.9433 euros on Euronext Paris, and 74 shares at 65.0200 euros on the CEUX platform. The following sessions involved volumes of 10,000 shares each, exclusively on the Paris market. Average prices gradually increased over the days, from 68.1028 euros on January 6 to 69.5790 euros on January 9. This progression reflects the evolution of prices during the period, without the group commenting on this trend.
Regulatory Compliance and Transparency
The disclosure of these transactions complies with the obligations set forth in Article 5(1)(b) of European Regulation No. 596/2014 concerning market abuse, the statement specifies. Eurofins Scientific provides the complete details of each individual transaction on its investor website, under the section dedicated to share buyback programs. The financial instrument involved bears the identification code FR0014000MR3, while the issuer is identified under the LEI code 529900JEHFM47DYY3S57. The group has not communicated the specific objectives of this buyback program or the prospects for the use of these self-held shares.
Purpose of the Share Buybacks
The statement does not provide any information on the purpose of these share buybacks. Eurofins Scientific has not indicated whether these shares are intended to be cancelled, allocated as part of employee share ownership plans, used for external growth operations, or retained to stabilize the share price. The total amount invested is approximately 4.72 million euros according to the data provided.
